instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Drug ineffective'? | Parenteral prostanoids for severe Group 3 pulmonary hypertension with right ventricular dysfunction.
Group 3 pulmonary hypertension (PH) is a common complication in patients with lung diseases but there are currently no FDA-approved therapies. The data is conflicting, but a few small studies suggest potential benefits ... | Fatal | ReactionOutcome | CC BY-NC-ND | 33841939 | 19,401,846 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | TOPIRAMATE | DrugsGivenReaction | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | TOPIRAMATE | DrugsGivenReaction | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hallucination, visual'. | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | TOPIRAMATE | DrugsGivenReaction | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | TOPIRAMATE | DrugsGivenReaction | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Unresponsive to stimuli'. | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | TOPIRAMATE | DrugsGivenReaction | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
What was the outcome of reaction 'Aggression'? | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | Recovered | ReactionOutcome | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
What was the outcome of reaction 'Agitation'? | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | Recovered | ReactionOutcome | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
What was the outcome of reaction 'Hallucination, visual'? | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | Recovered | ReactionOutcome | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
What was the outcome of reaction 'Mental disorder'? | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | Recovered | ReactionOutcome | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
What was the outcome of reaction 'Unresponsive to stimuli'? | Acute Topiramate Toxicity in a Five-Year-Old Child.
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargi... | Recovered | ReactionOutcome | CC BY | 33842124 | 19,200,921 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Milk-alkali syndrome'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oliguria'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polydipsia'. | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | CALCIUM, CALCIUM CARBONATE | DrugsGivenReaction | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the dosage of drug 'CALCIUM CARBONATE'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | ENTIRE BOTTLE DAILY | DrugDosageText | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Acute kidney injury'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Asthenia'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Decreased appetite'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Hypercalcaemia'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Milk-alkali syndrome'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Oliguria'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
What was the outcome of reaction 'Polydipsia'? | Calcium Alkali Syndrome Treated With Hemodialysis.
Malignancy, primary hyperparathyroidism, and vitamin D intoxication are the most common causes of hypercalcemia. Symptoms of hypercalcemia are nonspecific and require a plasma calcium level to diagnose. Undiagnosed hypercalcemia can cause renal failure long-term. Here,... | Recovered | ReactionOutcome | CC BY | 33842126 | 19,186,396 | 2021-03-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypovolaemic shock'. | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | ANAKINRA, CEFTRIAXONE, DEXAMETHASONE, LOPINAVIR\RITONAVIR, SPIRAMYCIN | DrugsGivenReaction | CC BY | 33842207 | 19,232,346 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | ANAKINRA, CEFTRIAXONE, DEXAMETHASONE, LOPINAVIR\RITONAVIR, SPIRAMYCIN | DrugsGivenReaction | CC BY | 33842207 | 19,232,346 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proctitis'. | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | ANAKINRA, CEFTRIAXONE, DEXAMETHASONE, LOPINAVIR\RITONAVIR, SPIRAMYCIN | DrugsGivenReaction | CC BY | 33842207 | 19,225,651 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | ANAKINRA, CEFTRIAXONE, DEXAMETHASONE, LOPINAVIR\RITONAVIR, OXYGEN, SPIRAMYCIN | DrugsGivenReaction | CC BY | 33842207 | 19,248,789 | 2021 |
What was the administration route of drug 'ANAKINRA'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Subcutaneous | DrugAdministrationRoute | CC BY | 33842207 | 19,232,346 | 2021 |
What was the administration route of drug 'DEXAMETHASONE'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33842207 | 19,232,346 | 2021 |
What was the administration route of drug 'LOPINAVIR\RITONAVIR'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Oral | DrugAdministrationRoute | CC BY | 33842207 | 19,232,346 | 2021 |
What was the dosage of drug 'OXYGEN'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | DECREASE | DrugDosageText | CC BY | 33842207 | 19,248,789 | 2021 |
What was the outcome of reaction 'Cytomegalovirus infection reactivation'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Recovered | ReactionOutcome | CC BY | 33842207 | 19,232,346 | 2021 |
What was the outcome of reaction 'Hypovolaemic shock'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Recovered | ReactionOutcome | CC BY | 33842207 | 19,232,346 | 2021 |
What was the outcome of reaction 'Large intestine infection'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Recovered | ReactionOutcome | CC BY | 33842207 | 19,232,346 | 2021 |
What was the outcome of reaction 'Proctitis'? | Cytomegalovirus proctitis as a complication of COVID-19 with immunosuppressive treatments.
We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found tha... | Recovered | ReactionOutcome | CC BY | 33842207 | 19,225,651 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal distension'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Deep vein thrombosis'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal obstruction'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver disorder'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | BORTEZOMIB, DEXAMETHASONE, DOXORUBICIN | DrugsGivenReaction | CC BY | 33842312 | 19,175,563 | 2021 |
What was the administration route of drug 'BORTEZOMIB'? | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33842312 | 19,175,563 | 2021 |
What was the administration route of drug 'DOXORUBICIN'? | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33842312 | 19,175,563 | 2021 |
What was the dosage of drug 'BORTEZOMIB'? | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | 1.3 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 33842312 | 19,175,563 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | 20 MILLIGRAM, QD | DrugDosageText | CC BY | 33842312 | 19,175,563 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety.
Although pegylated liposomal doxorubicin (PLD) has been approved in combination with bortezomib for relapsed/refractory multiple myeloma (MM)... | 40 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 33842312 | 19,175,563 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Hypereosinophilia in Solid Tumors-Case Report and Clinical Review.
Renal cell cancer may cause various paraneoplastic syndromes; however, paraneoplastic hypereosinophilia occurs exceedingly rare. Thus far, only two cases of clear cell renal cell carcinoma (CCRCC) associated with hypereosinophilia have been reported. In... | BUPRENORPHINE, METHYLPREDNISOLONE ACETATE, PANTOPRAZOLE | DrugsGivenReaction | CC BY | 33842345 | 20,085,778 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to bone'. | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | DENOSUMAB, EVEROLIMUS | DrugsGivenReaction | CC BY | 33842348 | 19,185,448 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | DENOSUMAB, EVEROLIMUS | DrugsGivenReaction | CC BY | 33842348 | 19,185,448 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to skin'. | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | DENOSUMAB, EVEROLIMUS | DrugsGivenReaction | CC BY | 33842348 | 19,185,448 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | DENOSUMAB, EVEROLIMUS | DrugsGivenReaction | CC BY | 33842348 | 19,185,448 | 2021 |
What was the administration route of drug 'DENOSUMAB'? | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | Subcutaneous | DrugAdministrationRoute | CC BY | 33842348 | 19,185,448 | 2021 |
What was the administration route of drug 'EVEROLIMUS'? | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | Oral | DrugAdministrationRoute | CC BY | 33842348 | 19,185,448 | 2021 |
What was the outcome of reaction 'Metastases to skin'? | VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated ... | Recovering | ReactionOutcome | CC BY | 33842348 | 19,185,448 | 2021 |
What was the outcome of reaction 'Coagulopathy'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
What was the outcome of reaction 'Hypokalaemia'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
What was the outcome of reaction 'Hyponatraemia'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
What was the outcome of reaction 'Liver injury'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
What was the outcome of reaction 'Myelosuppression'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
What was the outcome of reaction 'Pyrexia'? | Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report.
Immunotherapy has been proved to be a promising candidate for advanced non-small cell lung cancer (NSCLC). Despite MET mutations are regarded as an independent factor of programmed death ligand 1 (PD-L1) high exp... | Recovered | ReactionOutcome | CC BY-NC-ND | 33842645 | 19,130,126 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gas gangrene'. | Extensive clostridial myonecrosis after gluteal intramuscular injection in immunocompromised patient treated with surgical debridement and negative-pressure wound therapy.
Gas gangrene is infectious disease caused by Clostridium perfringens infection. We are presenting extremely rare case of gluteal clostridial myonecr... | AMOXICILLIN\CLAVULANIC ACID, CIPROFLOXACIN, CLINDAMYCIN, DICLOFENAC, METRONIDAZOLE | DrugsGivenReaction | CC BY | 33842680 | 19,191,027 | 2021-04 |
What was the outcome of reaction 'Gas gangrene'? | Extensive clostridial myonecrosis after gluteal intramuscular injection in immunocompromised patient treated with surgical debridement and negative-pressure wound therapy.
Gas gangrene is infectious disease caused by Clostridium perfringens infection. We are presenting extremely rare case of gluteal clostridial myonecr... | Recovered | ReactionOutcome | CC BY | 33842680 | 19,191,027 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,197,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normochromic anaemia'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,586,281 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normochromic normocytic anaemia'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,235,804 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product administration error'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus bradycardia'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,197,414 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular hypokinesia'. | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | METHADONE HYDROCHLORIDE, NALOXONE | DrugsGivenReaction | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Bradycardia'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,235,804 | 2021 |
What was the outcome of reaction 'Ejection fraction decreased'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Mental disorder'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Mental status changes'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,586,281 | 2021 |
What was the outcome of reaction 'Normochromic anaemia'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,586,281 | 2021 |
What was the outcome of reaction 'Normochromic normocytic anaemia'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Product administration error'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,235,804 | 2021 |
What was the outcome of reaction 'Sinus bradycardia'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Not recovered | ReactionOutcome | CC BY-NC | 33843317 | 19,281,131 | 2021 |
What was the outcome of reaction 'Sinus tachycardia'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,555,388 | 2021 |
What was the outcome of reaction 'Torsade de pointes'? | Methadone-Induced Polymorphic Ventricular Tachycardia Complicated by Takotsubo Cardiomyopathy in a Malnourished Patient.
Takotsubo cardiomyopathy (TC) is a syndrome characterized by acute and transient regional systolic myocardial dysfunction. TC often mimics myocardial infarction without obstructive coronary disease. ... | Recovering | ReactionOutcome | CC BY-NC | 33843317 | 19,235,804 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.